Document Detail

The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery.
MedLine Citation:
PMID:  22553194     Owner:  NLM     Status:  Publisher    
BACKGROUND: We conducted a population-based retrospective cohort study to investigate the influence of hospital volume, delay of surgery, and both together on the long-term survival of postoperative cancer patients. METHODS: Using information from the Korea Central Cancer Registry from 2001 through 2005 and the National Health Insurance claim database, we determined survival for 147 682 patients who underwent definitive surgery for any of six cancers. RESULTS: Regardless of cancer site, surgical patients in low- to medium-volume hospitals showed significantly worse survival [adjusted hazard ratio (aHR) = 1·36-1·86] than those in high-volume hospitals in multivariable analyses. Among the latter, treatment delays >1 month were not associated with worse survival for stomach, colon, pancreatic, or lung cancer but were for rectal [aHR = 1·28; 95% confidence interval (CI), 1·17-1·40] and breast (aHR = 1·59; 95% CI, 1·37-1·84) cancer. For patients in low- to medium-volume hospitals, treatment delay was associated with worse survival for all types of cancer (aHR = 1·78-3·81). CONCLUSION: Our findings suggest that the effect of hospital volume and surgical treatment delay on overall survival of cancer patients should be considered in formulating or revising national health policy.
Y H Yun; Y A Kim; Y H Min; S Park; Y J Won; D Y Kim; I J Choi; Y W Kim; S J Park; J H Kim; D H Lee; S J Yoon; S Y Jeong; D Y Noh; D S Heo
Related Documents :
19825814 - Local control of metastatic lung tumors treated with sbrt of 48 gy in four fractions: i...
16788954 - Modulation of the expression of superoxide dismutase gene in lung injury by 2-chloroeth...
9201284 - Possible role of indoor environment and coal combustion emission in lung carcinogenesis...
7821284 - Mutagenic and carcinogenic significance and the possible induction of lung cancer by ni...
20810384 - Synergistic antitumor activity of sorafenib in combination with epidermal growth factor...
12851694 - Advanced indications for gonadotropin-releasing hormone (gnrh) analogues in gynecologic...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-2
Journal Detail:
Title:  Annals of oncology : official journal of the European Society for Medical Oncology / ESMO     Volume:  -     ISSN:  1569-8041     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9007735     Medline TA:  Ann Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Cancer Research Institute, Seoul National University Hospital and College of Medicine, Seoul.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Suture-mediated arterial access site closure after transfemoral aortic valve implantation.
Next Document:  A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer.